REAL-TIME GLOBAL RESEARCH
PRADA Group: A really healthy delivery
Research evidence excerpt
PRADA Group: A really healthy delivery
Chiara Battistini AC Europe Equity Research
(39-02) 8895-2700 30 July 2026 J P M O R G A N
chiara.x.battistini@jpmorgan.com
Price Performance Summary Investment Thesis and Valuation
Investment Thesis
Prada is a key luxury goods player in Fashion & Leather Goods.
Its portfolio of brands includes Prada, Miu Miu, Versace,
Church’s, Car Shoe and Marchesi 1824. Following heavy
investments across the group between 2016 and 2019, Prada and
Miu Miu have been experiencing very solid momentum since
2021, benefitting from sustained product newness at the former
and high desirability at the latter, despite a multi-year very tough
comp. Such solid trends is driving the ongoing recovery of sales
densities with profitability following suit. We think there is
YTD 1m 3m 12m further potential for both brands to continue to extend their
Abs -15.8% -4.6% 9.2% -19.0% presence and lift their financial KPIs, increasingly catching up
Rel -16.7% -17.6% 8.9% -21.7%
with the other mega-brands in the luxury arena. While the
Company Data Versace acquisition adds execution risk in the short term and will
Shares O/S (mn) 2,559 require the Group to invest in restoring brand desirability and
52-week range (HK$) 52.00-34.52 profitability, we think Prada Group still offers some of the most
Market cap ($ mn) 12,366.20
Exchange rate 7.84 attractive fundamentals and valuation in the luxury sector, with
Free float (%) 20.0% earnings growth in the core Group continuing to run in double-
3M ADV (mn) 2.74 digits. We rate the stock Overweight.
3M ADV ($ mn) 13.1
Volatility (90 Day) 38 Valuation
Index HSI
BBG ANR (Buy | Hold | Sell) 15|9|1 Our Dec-27 DCF target price is based on FY26-FY30 explicit
forecasts, medium-term growth of 5.5%, terminal growth of
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer